David Cheresh

David Cheresh

University of California, San Diego

H-index: 141

North America-United States

About David Cheresh

David Cheresh, With an exceptional h-index of 141 and a recent h-index of 53 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of cell biology, cancer, angiogenesis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to create a fibronectin-rich extracellular matrix niche and promote tumor initiation

Inflammation mediated expression of integrin αvβ3 potentiates KRAS driven PDAC oncogenesis

STAT3 integration of inflammatory signals and cellular stress promote tumor initiation and progression through the expression of integrin β3

Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity

Compositions and methods for targeting and killing alpha-v beta-3-positive cancer stem cells (cscs) and treating drug resistant cancers

Lung cancer cells overcome nutrient stress by upregulating an integrin αvβ3/AMPK/OXPHOS axis

Arming tumor-associated macrophages to inhibit cancer progression

Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer

David Cheresh Information

University

Position

___

Citations(all)

81786

Citations(since 2020)

11830

Cited By

74706

hIndex(all)

141

hIndex(since 2020)

53

i10Index(all)

261

i10Index(since 2020)

158

Email

University Profile Page

University of California, San Diego

Google Scholar

View Google Scholar Profile

David Cheresh Skills & Research Interests

cell biology

cancer

angiogenesis

Top articles of David Cheresh

Title

Journal

Author(s)

Publication Date

Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to create a fibronectin-rich extracellular matrix niche and promote tumor initiation

Nature cell biology

Chengsheng Wu

Taha Rakhshandehroo

Hiromi I Wettersten

Alejandro Campos

Tami Von Schalscha

...

2023/2

Inflammation mediated expression of integrin αvβ3 potentiates KRAS driven PDAC oncogenesis

Cancer Research

Ryan M Shepard

Alejandro D Campos

Zachary M Ortega

Hiromi I Wettersten

Tami Von Schalscha

...

2024/3/22

STAT3 integration of inflammatory signals and cellular stress promote tumor initiation and progression through the expression of integrin β3

Cancer Research

Alejandro D Campos

Ryan Shepard

Ingrid Heumann

Justin Lam

Sara M Weis

...

2024/3/22

Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity

Cancer Research

Arin Nam

Shashi Jain

Chengsheng Wu

Alejandro Campos

Ryan M Shepard

...

2024/4/8

Compositions and methods for targeting and killing alpha-v beta-3-positive cancer stem cells (cscs) and treating drug resistant cancers

2021/2/4

Lung cancer cells overcome nutrient stress by upregulating an integrin αvβ3/AMPK/OXPHOS axis

Cancer Research

Arin Nam

Shashi Jain

Alejandro Campos

Ryan M Shepard

Tami von Schalscha

...

2024/3/22

Arming tumor-associated macrophages to inhibit cancer progression

Cancer Research

Joshua P Reddy

Ziqi Yu

Ryan M Shepard

Tami Von Schalscha

Stephen J McCormack

...

2024/3/22

Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer

Matrix Biology

Anna Testa

Fabio Quaglia

Nicole M Naranjo

Cecilia E Verrillo

Christopher D Shields

...

2023/12/1

Upregulation of fibronectin and its integrin receptors–an adaptation to isolation stress that facilitates tumor initiation

Chengsheng Wu

Sara M Weis

David A Cheresh

2023/10/15

Tumor-initiating cells establish a niche to overcome isolation stress

Chengsheng Wu

Sara M Weis

David A Cheresh

2023/8/26

Pancreas cancer cells upregulate LPAR4 in response to isolation stress to promote and ECM-enriched nice to support tumour initiation

Pancreatology

David Cheresh

2023/6/1

Compositions and methods for treating cancer

2014/6/12

Methods for treating drug resistant cancers

2023/12/28

Abstract P076: Humanized anti-αvβ3 antibody engineered to selectively promote macrophage-mediated cancer cell death

Cancer Immunology Research

Hiromi I Wettersten

Ryan M Shepard

Sara M Weis

David A Cheresh

2022/1/1

Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype

2021/7/6

Compositions and methods for identifying anti cancer, anti-metastatic and anti-stress agents

2021/6/1

COMPOSITIONS AND METHODS FOR TARGETING AND DESTRUCTION OF ALPHA-V BETA-3 POSITIVE CANCER STEM CELLS (CCS) AND TREATMENT OF DRUG-RESISTANT CANCERS

2021/1/13

Metastasis is a highly stressful process

Alejandro D Campos

Sara M Weis

David A Cheresh

2020/12

Zika virus targets glioblastoma stem cells through a SOX2-integrin αvβ5 axis

Cell stem cell

Zhe Zhu

Pinar Mesci

Jean A Bernatchez

Ryan C Gimple

Xiuxing Wang

...

2020/2/6

See List of Professors in David Cheresh University(University of California, San Diego)